MedPath

Vigabatrin

These highlights do not include all the information needed to use VIGABATRIN FOR ORAL SOLUTION safely and effectively. See full prescribing information for VIGABATRIN FOR ORAL SOLUTION. VIGABATRIN for oral solution Initial U.S. Approval: 2009

Approved
Approval ID

f6be436e-46c7-e9ab-0fcf-e8d04dc12b72

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 11, 2021

Manufacturers
FDA

Dr. Reddys Laboratories Inc.,

DUNS: 802315887

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Vigabatrin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43598-697
Application NumberANDA211481
Product Classification
M
Marketing Category
C73584
G
Generic Name
Vigabatrin
Product Specifications
Route of AdministrationORAL
Effective DateNovember 11, 2021
FDA Product Classification

INGREDIENTS (2)

PovidoneInactive
Code: FZ989GH94E
Classification: IACT
VigabatrinActive
Quantity: 50 mg in 1 mL
Code: GR120KRT6K
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.